A carregar...
Deferasirox-induced urticarial vasculitis in a patient with myelodysplastic syndrome
Deferasirox is an iron chelator agent used in the treatment of diseases with iron overload, such as thalassemia and myelodysplastic syndrome. Although the majority of adverse reactions of deferasirox involve gastrointestinal symptoms and increase in serum creatinine and transaminases, skin rashes, s...
Na minha lista:
| Publicado no: | An Bras Dermatol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Sociedade Brasileira de Dermatologia
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5726679/ https://ncbi.nlm.nih.gov/pubmed/29267448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/abd1806-4841.20176688 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|